BioTrove, Inc. has announced that the Stanford University Genome Technology Center will advance multiple research projects through the use of the BioTrove OpenArray™ technology platform. Researchers ...

BioTrove has announced that Charles River Laboratories will use the BioTrove OpenArray™ system to detect rodent-specific pathogens as part of their effort to evaluate the health of rodent species.

Novel device tests blood for 17 viruses and 13 bacterial and protozoan pathogens simultaneously with 95% accuracy, comparable with existing FDA-approved tests, reports The Journal of Molecular ...

Addition of OpenArray technology to Applied Biosystems segment is expected to provide improved assay content. Life Technologies is acquiring BioTrove, maker of the high-throughput gene-expression and ...

CARLSBAD, Calif.--(BUSINESS WIRE)--Nov. 10, 2009-- Life Technologies Corporation (NASDAQ:LIFE), a provider of innovative life science solutions, today announced that it has signed a definitive ...

The OpenArray® Real-Time PCR Platform puts the control in the hands to get the answers you need. It delivers the best combination of convenience, flexibility, throughput, and cost-effectiveness for ...

imaGenes will complement its offerings with BioTrove’s OpenArray® platform, a nanoliter real-time qPCR system that allows for about 9,000 assays simultaneously. imaGenes is BioTrove’s first OpenArray ...

Genotyping was performed on the TaqMan Openarray AccuFill System (Life Technologies, NY, USA) using 64 SNP per array. Briefly, 2.5 μl of DNA (50 ng/μl) was mixed with 2.5 μl of the TaqMan OpenArray ...